These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3958270)

  • 41. [Oral 8-methoxypsoralen-UVA (PUVA) therapy in psoriasis: comparison of 3 treatment protocols].
    Hofmann C; Neiss A; Plewig G; Braun-Falco O
    Hautarzt; 1980 Jun; 31(6):315-23. PubMed ID: 6893320
    [No Abstract]   [Full Text] [Related]  

  • 42. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis.
    Gordon PM; Diffey BL; Matthews JN; Farr PM
    J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):728-32. PubMed ID: 10534635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psoralens and related compounds in the treatment of psoriasis.
    McEvoy MT; Stern RS
    Pharmacol Ther; 1987; 34(1):75-97. PubMed ID: 3310045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. A 10-year follow-up study.
    Torinuki W; Tagami H
    J Am Acad Dermatol; 1988 Jun; 18(6):1278-81. PubMed ID: 3385042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy.
    Hunt MJ; Lee SH; Salisbury EL; Wills EJ; Armati R
    Australas J Dermatol; 1997 Nov; 38(4):199-201. PubMed ID: 9431715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of PUVA.
    Roenigk HH
    JAMA; 1981 May; 245(19):1941. PubMed ID: 6785457
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis.
    Lowe NJ; Urbach F; Bailin P; Weingarten DP
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):994-8. PubMed ID: 3294946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): findings before and after 1 year of therapy in twelve patients. A blind study and review of literature on hepatotoxicity of PUVA.
    Nyfors A; Dahl-Nyfors B; Hopwood D
    J Am Acad Dermatol; 1986 Jan; 14(1):43-8. PubMed ID: 3950113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis.
    Morison WL; Parrish JA; Fitzpatrick TB
    Br J Dermatol; 1978 Feb; 98(2):125-32. PubMed ID: 629867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical 8-methoxypsoralen photochemotherapy of psoriasis: a clinical study.
    Danno K; Horio T; Ozaki M; Imamura S
    Br J Dermatol; 1983 May; 108(5):519-24. PubMed ID: 6342648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
    Pham CT; Koo JY
    J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current status of oral PUVA therapy for psoriasis. Eye protection revisions.
    J Am Acad Dermatol; 1982 May; 6(5):851-5. PubMed ID: 7096648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Photochemotherapy (PUVA) in psoriasis and vitiligo.
    Shenoi SD; Prabhu S;
    Indian J Dermatol Venereol Leprol; 2014; 80(6):497-504. PubMed ID: 25382505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.